1. Epstein Barr virus associated smooth muscle tumors in the central nervous system: a case report and systematic review of the literature

   • V. M. Willeke
   • M. P. Anderson
   • E. M. Kasper

   Topic Review 05 March 2020 Pages: 247 - 260

   

2. Super selective intra-arterial cerebral infusion of modern chemotherapeutics after blood–brain barrier disruption: where are we now, and where we are going

   • Randy S. D’Amico
   • Deepak Khatri
   • John A. Boockvar

   Topic Review 19 February 2020 Pages: 261 - 278

   

3. Correction to: Super selective intra‑arterial cerebral infusion of modern chemotherapeutics after blood–brain barrier disruption: where are we now, and where we are going

   • Randy S. D’Amico
   • Deepak Khatri
   • John A. Boockvar

   Correction 13 March 2020 Pages: 279 - 279

4. T-Cell based therapies for overcoming neuroanatomical and immunosuppressive challenges within the glioma microenvironment

   • Darwin Kwok
   • Hideho Okada

   Topic Review 17 March 2020 Pages: 281 - 295

   

5. Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis

   • Lina Marenco-Hillembrand
   • Olindi Wijesekera
   • Kaisorn L. Chaichana

   Topic Review 09 March 2020 Pages: 297 - 307

   

6. A genome-wide association study on medulloblastoma

   • Anna M. Dahlin
   • Carl Wibom
   • Beatrice Melin

   Laboratory Investigation Open access 13 February 2020 Pages: 309 - 315

   

7. The contribution of ketone bodies to glycolytic inhibition for the treatment of adult and pediatric glioblastoma

   • Frederic A. Vallejo
   • Sumedh S. Shah
   • Regina M. Graham

   Laboratory Investigation 24 February 2020 Pages: 317 - 326

   

8. Reciprocal control of ADAM17/EGFR/Akt signaling and miR-145 drives GBM invasiveness

   • Yuduo Guo
   • Xin He
   • Hongwei Zhang

   Laboratory Investigation 13 March 2020 Pages: 327 - 337

   

9. Primary central nervous system lymphoma involving the hypothalamic–pituitary axis: a case series and pooled analysis

   • Dong-Won Shin
   • Jeong Hoon Kim
   • Seok Ho Hong

   Clinical Study 27 March 2020 Pages: 339 - 349

   

10. LINAC-based stereotactic radiosurgery versus hypofractionated stereotactic radiotherapy delivered in 3 or 5 fractions for vestibular schwannomas: comparative assessment from a single institution

    • Linn Söderlund Diaz
    • Andreas Hallqvist

    Clinical Study 08 February 2020 Pages: 351 - 359

    

11. Disparities in glioblastoma survival by case volume: a nationwide observational study

    • Rahul Raj
    • Karri Seppä
    • Miikka Korja

    Clinical Study Open access 14 February 2020 Pages: 361 - 370

    

12. Fertility preservation outcomes in women with gliomas: a retrospective case–control study

    • Taylor Nordan
    • Ann M. Thomas
    • Pietro Bortoletto

    Clinical Study 14 February 2020 Pages: 371 - 376

13. Surgical treatment and survival outcome of patients with adult thalamic glioma: a single institution experience of 8 years

    • Xiaodong Niu
    • Tianwei Wang
    • Qing Mao

    Clinical Study 10 March 2020 Pages: 377 - 386

    

14. Clinical outcomes following proton therapy for adult craniopharyngioma: a single-institution cohort study

    • Michael S. Rutenberg
    • Ronny L. Rotondo
    • William M. Mendenhall

    Clinical Study 21 February 2020 Pages: 387 - 395

    

15. The prevalence of altered body image in patients with primary brain tumors: an understudied population

    • Lindsay Rowe
    • Elizabeth Vera
    • Terri Armstrong

    Clinical Study Open access 24 February 2020 Pages: 397 - 404

16. Extent of re-excision, sequence/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymoma

    • Tejpal Gupta
    • Madan Maitre
    • Jayant GodaSastri

    Clinical Study 18 February 2020 Pages: 405 - 415

    

17. Variations in screening and management practices for subsequent asymptomatic meningiomas in childhood, adolescent and young adult cancer survivors

    • Lisanne C. Verbruggen
    • Melissa M. Hudson
    • Renée L. Mulder

    Clinical Study 22 February 2020 Pages: 417 - 425

    

18. Clinical presentation of young people (10–24 years old) with brain tumors: results from the international MOBI-Kids study

    • Angela Zumel-Marne
    • Michael Kundi
    • Elisabeth Cardis

    Clinical Study Open access 03 March 2020 Pages: 427 - 440

    

19. Long-term outcomes of multimodality management for parasagittal meningiomas

    • Lingyang Hua
    • Daijun Wang
    • Ye Gong

    Clinical Study 22 February 2020 Pages: 441 - 450

    

20. Improvement in resiliency factors among adolescents with neurofibromatosis who participate in a virtual mind–body group program

    • Ethan G. Lester
    • Eric A. Macklin
    • Ana-Maria Vranceanu

    Clinical Study 20 February 2020 Pages: 451 - 457

21. Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience

    • Vera Espírito Santo
    • João Passos
    • Sofia Nunes

    Clinical Study 27 February 2020 Pages: 459 - 463

22. Outcomes after stereotactic radiosurgery for CNS lymphoma

    • Joshua D. Palmer
    • Deepak Bhamidipati
    • Wenyin Shi

    Clinical Study 27 February 2020 Pages: 465 - 476

    

23. Patterns of relapse after successful completion of initial therapy in primary central nervous system lymphoma: a case series

    • Mallika P. Patel
    • John P. Kirkpatrick
    • Katherine B. Peters

    Clinical Study 05 March 2020 Pages: 477 - 483

    

24. Healthcare utilization and productivity loss in glioma patients and family caregivers: the impact of treatable psychological symptoms

    • Florien W. Boele
    • David Meads
    • Martin Klein

    Clinical Study Open access 14 March 2020 Pages: 485 - 494

25. Racial and socioeconomic correlates of treatment and survival among patients with meningioma: a population-based study

    • Hriday P. Bhambhvani
    • Adrian J. Rodrigues
    • Melanie Hayden Gephart

    Clinical Study 19 March 2020 Pages: 495 - 501